Clinical and echocardiographic preoperative data in the ‘MitraClip’ and ‘Surgical edge-to-edge’ groups
. | MitraClip group n = 85 . | Surgical EE group n = 58 . | P -value . |
---|---|---|---|
Male gender ( n , %) | 70 (82) | 40 (69) | 0.06 |
Age (years) | 69 ± 9.4 | 62 ± 10.1 | 0.0001 |
Ischaemic DCM ( n , %) | 62 (73) | 36 (62) | 0.1 |
NYHA class ( n , %) | 0.9 | ||
II | 13 (15) | 9 (15) | |
III | 57 (67) | 36 (62) | |
IV | 15 (17) | 13 (22) | |
Atrial fibrillation ( n , %) | 24 (28) | 12 (20) | 0.3 |
Log EuroSCORE | 19 ± 15.9 | 11.4 ± 3.2 | 0.04 |
LVEF (%) | 28 ± 9.7 | 28 ± 6.5 | 0.4 |
LVEDD (mm) | 67 ± 7.8 | 69 ± 5.8 | 0.1 |
LVESD (mm) | 54 ± 9.1 | 52 ± 7.9 | 0.3 |
LVEDV (ml) | 188 ± 66.2 | 203 ± 58.02 | 0.1 |
SPAP (mmHg) | 47 ± 14.2 | 48 ± 13.2 | 0.5 |
SPAP > 40 mmHg ( n , %) | 46 (54) | 33 (56) | 0.1 |
TR 3+ or 4+ ( n , %) | 17 (20) | 11 (19) | 0.8 |
Coaptation depth (cm) | 1.2 ± 0.34 | 1.2 ± 0.46 | 0.5 |
Tented area (cm 2 ) | 2.8 ± 0.99 | 2.8 ± 0.88 | 0.6 |
. | MitraClip group n = 85 . | Surgical EE group n = 58 . | P -value . |
---|---|---|---|
Male gender ( n , %) | 70 (82) | 40 (69) | 0.06 |
Age (years) | 69 ± 9.4 | 62 ± 10.1 | 0.0001 |
Ischaemic DCM ( n , %) | 62 (73) | 36 (62) | 0.1 |
NYHA class ( n , %) | 0.9 | ||
II | 13 (15) | 9 (15) | |
III | 57 (67) | 36 (62) | |
IV | 15 (17) | 13 (22) | |
Atrial fibrillation ( n , %) | 24 (28) | 12 (20) | 0.3 |
Log EuroSCORE | 19 ± 15.9 | 11.4 ± 3.2 | 0.04 |
LVEF (%) | 28 ± 9.7 | 28 ± 6.5 | 0.4 |
LVEDD (mm) | 67 ± 7.8 | 69 ± 5.8 | 0.1 |
LVESD (mm) | 54 ± 9.1 | 52 ± 7.9 | 0.3 |
LVEDV (ml) | 188 ± 66.2 | 203 ± 58.02 | 0.1 |
SPAP (mmHg) | 47 ± 14.2 | 48 ± 13.2 | 0.5 |
SPAP > 40 mmHg ( n , %) | 46 (54) | 33 (56) | 0.1 |
TR 3+ or 4+ ( n , %) | 17 (20) | 11 (19) | 0.8 |
Coaptation depth (cm) | 1.2 ± 0.34 | 1.2 ± 0.46 | 0.5 |
Tented area (cm 2 ) | 2.8 ± 0.99 | 2.8 ± 0.88 | 0.6 |
LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV: left ventricular end-diastolic volume; SPAP: systolic pulmonary artery pressure; TR: tricuspid regurgitation; EE: edge-to-edge; NYHA: New York Heart Association; DCM: dilated cardiomyopathy.
Clinical and echocardiographic preoperative data in the ‘MitraClip’ and ‘Surgical edge-to-edge’ groups
. | MitraClip group n = 85 . | Surgical EE group n = 58 . | P -value . |
---|---|---|---|
Male gender ( n , %) | 70 (82) | 40 (69) | 0.06 |
Age (years) | 69 ± 9.4 | 62 ± 10.1 | 0.0001 |
Ischaemic DCM ( n , %) | 62 (73) | 36 (62) | 0.1 |
NYHA class ( n , %) | 0.9 | ||
II | 13 (15) | 9 (15) | |
III | 57 (67) | 36 (62) | |
IV | 15 (17) | 13 (22) | |
Atrial fibrillation ( n , %) | 24 (28) | 12 (20) | 0.3 |
Log EuroSCORE | 19 ± 15.9 | 11.4 ± 3.2 | 0.04 |
LVEF (%) | 28 ± 9.7 | 28 ± 6.5 | 0.4 |
LVEDD (mm) | 67 ± 7.8 | 69 ± 5.8 | 0.1 |
LVESD (mm) | 54 ± 9.1 | 52 ± 7.9 | 0.3 |
LVEDV (ml) | 188 ± 66.2 | 203 ± 58.02 | 0.1 |
SPAP (mmHg) | 47 ± 14.2 | 48 ± 13.2 | 0.5 |
SPAP > 40 mmHg ( n , %) | 46 (54) | 33 (56) | 0.1 |
TR 3+ or 4+ ( n , %) | 17 (20) | 11 (19) | 0.8 |
Coaptation depth (cm) | 1.2 ± 0.34 | 1.2 ± 0.46 | 0.5 |
Tented area (cm 2 ) | 2.8 ± 0.99 | 2.8 ± 0.88 | 0.6 |
. | MitraClip group n = 85 . | Surgical EE group n = 58 . | P -value . |
---|---|---|---|
Male gender ( n , %) | 70 (82) | 40 (69) | 0.06 |
Age (years) | 69 ± 9.4 | 62 ± 10.1 | 0.0001 |
Ischaemic DCM ( n , %) | 62 (73) | 36 (62) | 0.1 |
NYHA class ( n , %) | 0.9 | ||
II | 13 (15) | 9 (15) | |
III | 57 (67) | 36 (62) | |
IV | 15 (17) | 13 (22) | |
Atrial fibrillation ( n , %) | 24 (28) | 12 (20) | 0.3 |
Log EuroSCORE | 19 ± 15.9 | 11.4 ± 3.2 | 0.04 |
LVEF (%) | 28 ± 9.7 | 28 ± 6.5 | 0.4 |
LVEDD (mm) | 67 ± 7.8 | 69 ± 5.8 | 0.1 |
LVESD (mm) | 54 ± 9.1 | 52 ± 7.9 | 0.3 |
LVEDV (ml) | 188 ± 66.2 | 203 ± 58.02 | 0.1 |
SPAP (mmHg) | 47 ± 14.2 | 48 ± 13.2 | 0.5 |
SPAP > 40 mmHg ( n , %) | 46 (54) | 33 (56) | 0.1 |
TR 3+ or 4+ ( n , %) | 17 (20) | 11 (19) | 0.8 |
Coaptation depth (cm) | 1.2 ± 0.34 | 1.2 ± 0.46 | 0.5 |
Tented area (cm 2 ) | 2.8 ± 0.99 | 2.8 ± 0.88 | 0.6 |
LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV: left ventricular end-diastolic volume; SPAP: systolic pulmonary artery pressure; TR: tricuspid regurgitation; EE: edge-to-edge; NYHA: New York Heart Association; DCM: dilated cardiomyopathy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.